BeOne Medicines AG (ONC) stock analysis
ONC · BeOne Medicines AG
Latest recorded price: USD 411.29
Sector and industry: Healthcare · Biotechnology
A reliable intrinsic value could not be calculated for ONC; the assessment relies on sector multiple comparisons. Fiscal 2025 figures: revenue growth 55.7%, free cash flow margin 17.6%. The model flags 1 risk signal for this company.
Similar companies in Healthcare
- Oruka Therapeutics, Inc. (ORKA)
- Precigen, Inc. (PGEN)
- Praxis Precision Medicines, Inc. (PRAX)
- PTC Therapeutics, Inc. - Common Stock (PTCT)
- Palvella Therapeutics, Inc. (PVLA)
- Ultragenyx Pharmaceutical Inc. - Common Stock (RARE)
- Arcus Biosciences, Inc. (RCUS)
- Regeneron Pharmaceuticals, Inc. - Common Stock (REGN)